2021年1月4日 · Here we briefly review our current knowledge of the biology, pathophysiology and epidemiology of a potential multidrug-resistant fungal pathogen, C. krusei, while also discussing the mechanisms of drug resistance of Candida species and alternative therapeutic approaches.

Candida krusei is well known as a fungal pathogen for patients with hematologic malignancies and for transplant recipients.

Pichia kudriavzevii (formerly Candida krusei [1] [2]) is a budding yeast (a species of fungus) involved in chocolate production. P. kudriavzevii is an emerging fungal nosocomial pathogen [ 3 ] primarily found in the immunocompromised and those with hematological malignancies.

2024年5月12日 · C. krusei is responsible for many systemic and local fungal infections, portraying a crucial impact of the fungal pathogenesis. Did you know that different strains of the fungal diploid, opportunistic, pathogen C. krusei are used commercially in …

2024年4月24日 · Candida albicans, C. glabrata, C. parapsilosis, C. tropicalis, and C. krusei are most common. Species distribution varies by patient population and geographic region.

Pichia kudriavzevii (C. krusei) causes severe infections in various organs and tissues including urinary, respiratory, and gastrointestinal tract and bloodstream. This can be explained by its ability to adhere to host tissue and form biofilms.

A patient was determined to have candidemia if C krusei or C albicans was isolated from at least 1 blood culture specimen, associated with fever or signs of organ infection.

2023年7月26日 · C. krusei is a species of yeast and an opportunistic fungal pathogen that can cause infections in humans, especially in individuals with compromised immune systems or underlying medical conditions. Morphologically, it appears as oval-shaped or ellipsoidal yeast cells that reproduce through budding.

2025年1月13日 · C. krusei is a diploid, dimorphic ascomycetous yeast that colonizes the mucosa of healthy individuals. However, this yeast can cause life-threatening infections in immunocompromised patients, with patients with hematologic malignancies and patients receiving prolonged azole prophylaxis being at higher risk.

2024年7月28日 · Recent strides in medical mycology have shed light on the formidable pathogen, Candida krusei. Known for its intrinsic resistance to certain antifungal treatments and its role in opportunistic infections, this yeast poses significant challenges in clinical settings.